The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network.

Autor: Mohammad S Hossain, Robert J Commons, Nicholas M Douglas, Kamala Thriemer, Bereket H Alemayehu, Chanaki Amaratunga, Anupkumar R Anvikar, Elizabeth A Ashley, Puji B S Asih, Verena I Carrara, Chanthap Lon, Umberto D'Alessandro, Timothy M E Davis, Arjen M Dondorp, Michael D Edstein, Rick M Fairhurst, Marcelo U Ferreira, Jimee Hwang, Bart Janssens, Harin Karunajeewa, Jean R Kiechel, Simone Ladeia-Andrade, Moses Laman, Mayfong Mayxay, Rose McGready, Brioni R Moore, Ivo Mueller, Paul N Newton, Nguyen T Thuy-Nhien, Harald Noedl, Francois Nosten, Aung P Phyo, Jeanne R Poespoprodjo, David L Saunders, Frank Smithuis, Michele D Spring, Kasia Stepniewska, Seila Suon, Yupin Suputtamongkol, Din Syafruddin, Hien T Tran, Neena Valecha, Michel Van Herp, Michele Van Vugt, Nicholas J White, Philippe J Guerin, Julie A Simpson, Ric N Price

Publikováno v: PLoS Medicine, Vol 17, Iss 11, p e1003393 (2020)

BackgroundThere is a high risk of Plasmodium vivax parasitaemia following treatment of falciparum malaria. Our study aimed to quantify this risk and the associated determinants using an individual patient data meta-analysis in order to identify popul

Externí odkaz: https://doaj.org/article/4f40c1cb6f224e8d8aa90378a7feca88

Artemisinin-naphthoquine versus artemether-lumefantrine for uncomplicated malaria in Papua New Guinean children: an open-label randomized trial.

Autor: Moses Laman, Brioni R Moore, John M Benjamin, Gumul Yadi, Cathy Bona, Jonathan Warrel, Johanna H Kattenberg, Tamarah Koleala, Laurens Manning, Bernadine Kasian, Leanne J Robinson, Naomi Sambale, Lina Lorry, Stephan Karl, Wendy A Davis, Anna Rosanas-Urgell, Ivo Mueller, Peter M Siba, Inoni Betuela, Timothy M E Davis

Publikováno v: PLoS Medicine, Vol 11, Iss 12, p e1001773 (2014)

BackgroundArtemisinin combination therapies (ACTs) with broad efficacy are needed where multiple Plasmodium species are transmitted, especially in children, who bear the brunt of infection in endemic areas. In Papua New Guinea (PNG), artemether-lumef

Externí odkaz: https://doaj.org/article/ef696de515304ce4b62fb7e240ed75be

The Physicochemical Compatibility of Sildenafil Injection with Parenteral Medications Used in Neonatal Intensive Care Settings

Autor: D. Thisuri N. De Silva, Tobias Strunk, Michael Petrovski, Madhu Page-Sharp, Brioni R. Moore, Kevin T. Batty

Publikováno v: Pharmaceutics, Vol 16, Iss 3, p 419 (2024)

Sildenafil is used to treat pulmonary hypertension in neonatal intensive care unit (NICU) settings. As multiple intravenous (IV) medications are co-administered in NICU settings, we sought to investigate the physicochemical compatibility of sildenafi

Externí odkaz: https://doaj.org/article/99a55c668f4c4fce91a73fc3823cdc48

Ultra-short course, high-dose primaquine to prevent Plasmodium vivax infection following uncomplicated pediatric malaria: A randomized, open-label, non-inferiority trial of early versus delayed treatment

Autor: Sze-Ann Woon, Brioni R. Moore, Moses Laman, Paula Tesine, Lina Lorry, Bernadine Kasian, Phantica Yambo, Gumul Yadi, William Pomat, Kevin T. Batty, Sam Salman, Leanne J. Robinson, Timothy M.E. Davis, Laurens Manning

Publikováno v: International Journal of Infectious Diseases. 130:189-195

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d62d69ea581fd74ff8b84e793342d39e
https://doi.org/10.1016/j.ijid.2023.03.010

Piperaquine Pharmacokinetic and Pharmacodynamic Profiles in Healthy Volunteers of Papua New Guinea after Administration of Three-Monthly Doses of Dihydroartemisinin–Piperaquine

Autor: Pere Millat-Martínez, Sam Salman, Brioni R. Moore, Bàrbara Baro, Madhu Page-Sharp, Kevin T. Batty, Leanne J. Robinson, William Pomat, Harin Karunajeewa, Moses Laman, Laurens Manning, Oriol Mitjà, Quique Bassat

Publikováno v: Antimicrob Agents Chemother
Antimicrobial Agents And Chemotherapy
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

Mass drug administration (MDA) with monthly dihydroartemisinin-piperaquine (DHA-PQP) appears useful in malaria control and elimination strategies. Determining the relationship between consecutive piperaquine phosphate (PQP) exposure and its impact on

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a94187636959c38842fa1fdda49609b4
https://europepmc.org/articles/PMC9380548/